1. Home
  2. SRRK vs ATAT Comparison

SRRK vs ATAT Comparison

Compare SRRK & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$48.29

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Atour Lifestyle Holdings Limited

ATAT

Atour Lifestyle Holdings Limited

HOLD

Current Price

$33.61

Market Cap

5.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
ATAT
Founded
2012
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.1B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
SRRK
ATAT
Price
$48.29
$33.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
4
Target Price
$56.17
$49.00
AVG Volume (30 Days)
1.1M
991.5K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
2.06%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$25.48
Revenue Next Year
$534.24
$18.11
P/E Ratio
N/A
$26.11
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$29.81
52 Week High
$51.63
$43.17

Technical Indicators

Market Signals
Indicator
SRRK
ATAT
Relative Strength Index (RSI) 51.79 34.27
Support Level $45.28 N/A
Resistance Level $51.34 $39.19
Average True Range (ATR) 2.39 1.47
MACD -0.06 -0.42
Stochastic Oscillator 50.94 1.48

Price Performance

Historical Comparison
SRRK
ATAT

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About ATAT Atour Lifestyle Holdings Limited

Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.

Share on Social Networks: